Janus Living, Inc. <JAN.N>: Wells Fargo Raises Target Price to $35 From $33
JAN•Related News
BioXcel Therapeutics secures USD 77.25 million DIP financing from Oaktree, Qatar Investment Authority affiliates
BTAI•
DocGo CEO to speak at Morgan Stanley Global Healthcare Conference
DCGO•
A10 Networks Inc <ATEN.N>: Deutsche Bank initiates coverage with hold rating and target price $28
ATEN•
Clearmind Medicine starts Phase IIa CMND-100 trial in alcohol use disorder patients
CMND•
RedHill Biopharma buys commercialization rights to Ferring’s Rebyota, Clenpiq for $12 million upfront
RDHL•